Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Systematic cardio-oncologic screening of patients treated with BRAF and MEK inhibitors

BRAF and MEK inhibitors have significantly improved progression-free and overall survival compared to monotherapy, they carry a high risk of cardiovascular adverse events (CVAEs) because the MAPK pathway is also essential for normal cardiac and vascular physiology. The ESC Guidelines on Cardio-Oncology recommend...

F. Guerra, E. Rrapaj, A. Frangione et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.